Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety

References

• Headache Classification Committee of the International Headache Society (IHS)The International Classification of Headache Disorders3rd ed (beta version)Cephalalgia201333962980823771276
   PubMed Web of Science ®Google Scholar
• NatoliJLManackADeanBGlobal prevalence of chronic migraine: a systematic reviewCephalalgia201030559960919614702
   PubMed Web of Science ®Google Scholar
• BuseDCManackANFanningKMChronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention StudyHeadache201352101456147022830411
   PubMed Web of Science ®Google Scholar
• BigalMESheftellFDRapoportAMLiptonRBTepperSJChronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headacheCephalalgia200222643243812133042
   PubMed Web of Science ®Google Scholar
• DodickDWClinical practice. Chronic daily headacheN Engl J Med2006354215816516407511
   PubMed Web of Science ®Google Scholar
• BigalMESerranoDReedMLiptonRBChronic migraine in the population: burden, diagnosis, and satisfaction with treatmentNeurology200871855956618711108
   PubMed Web of Science ®Google Scholar
• BigalMERapoportAMLiptonRBTepperSJSheftellFDAssessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraineHeadache200343433634212656704
   PubMed Web of Science ®Google Scholar
• BlumenfeldAMVaronSFWilcoxTKDisability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)Cephalalgia201131330131520813784
   PubMed Web of Science ®Google Scholar
• StewartWFWoodGCManackAVaronSFBuseDCLiptonRBEmployment and work impact of chronic migraine and episodic migraineJ Occup Environ Med201052181420042889
   PubMed Web of Science ®Google Scholar
• BuseDCSilbersteinSDManackANPapapetropoulosSLiptonRBPsychiatric comorbidities of episodic and chronic migraineJ Neurol201326081960196923132299
   PubMed Web of Science ®Google Scholar
• AshinaSSerranoDLiptonRBDepression and risk of transformation of episodic to chronic migraineJ Headache Pain201213861562423007859
   PubMed Web of Science ®Google Scholar
• BuseDCManackASerranoDTurkelCLiptonRBSociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferersJ Neurol Neurosurg Psychiatry201081442843220164501
   PubMed Web of Science ®Google Scholar
• BuseDManackASerranoDHeadache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention studyHeadache201252131722106869
   PubMed Web of Science ®Google Scholar
• BigalMELiptonRBTepperSJRapoportAMSheftellFDPrimary chronic daily headache and its subtypes in adolescents and adultsNeurology200463584384715365134
   PubMed Web of Science ®Google Scholar
• DienerHCLimmrothVMedication-overuse headache: a worldwide problemLancet Neurol20043847548315261608
   PubMed Web of Science ®Google Scholar
• LiptonRBBigalMEChronic daily headache: is analgesic overuse a cause or a consequence?Neurology200361215415512874389
   PubMed Web of Science ®Google Scholar
• NegroAMartellettiPChronic migraine plus medication overuse headache: two entities or not?J Headache Pain201112659360121938457
   PubMed Web of Science ®Google Scholar
• SilbersteinSDPractice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology200055675476210993991
   PubMed Web of Science ®Google Scholar
• LiptonRBBigalMEDiamondMFreitagFReedMLStewartWFPREEMPT Chronic Migraine Study GroupMigraine prevalence, disease burden, and the need for preventive therapyNeurology200768534334917261680
   PubMed Web of Science ®Google Scholar
• DodickDWTurkelCCDeGryseREPREEMPT Chronic Migraine Study GroupOnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical programHeadache201050692193620487038
   PubMed Web of Science ®Google Scholar
• LiptonRBVaronSFGrosbergBOnabotulinumtoxinA improves quality of life and reduces impact of chronic migraineNeurology201177151465147221956721
   PubMed Web of Science ®Google Scholar
• JuangKDWangSJFuhJLLuSRSuTPComorbidity of depressive and anxiety disorders in chronic daily headache and its subtypesHeadache2000401081882311135026
   PubMed Web of Science ®Google Scholar
• ZwartJADybGHagenKDahlAABovimGStovnerLJDepression and anxiety disorders associated with headache frequency. The Nord-Trøndelag Health StudyEur J Neurol200310214715212603289
   PubMed Web of Science ®Google Scholar
• RadatFSwendsenJPsychiatric comorbidity in migraine: a reviewCephalalgia200525316517815689191
   PubMed Web of Science ®Google Scholar
• DienerHCDodickDWAuroraSKPREEMPT 2 Chronic Migraine Study GroupOnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trialCephalalgia201030780481420647171
   PubMed Web of Science ®Google Scholar
• OlesenJBousserMGDienerHCHeadache Classification CommitteeNew appendix criteria open for a broader concept of chronic migraineCephalalgia200626674274616686915
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision (DSM-IV-TR)Arlington, VAAmerican Psychiatric Press Inc2000
   Google Scholar
• Headache Classification Subcommittee of the International Headache SocietyThe International Classification of Headache Disorders2nd edCephalalgia200424Suppl 1S9S160
   PubMed Web of Science ®Google Scholar
• BaylissMSBatenhorstASThe HIT-6: A User’s GuideLincoln, RIQualityMetric, Inc2002
   Google Scholar
• StewartWFLiptonRBDowsonAJSawyerJDevelopment and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disabilityNeurology2001566 Suppl 1S20S2811294956
   PubMed Web of Science ®Google Scholar
• BeckATSteerRABallRRanieriWComparison of Beck Depression Inventories-IA and -II in psychiatric outpatientsJ Pers Assess19966735885978991972
   PubMed Web of Science ®Google Scholar
• KroenkeKSpitzerRLWilliamsJBThe PHQ-9: validity of a brief depression severity measureJ Gen Intern Med200116960661311556941
   PubMed Web of Science ®Google Scholar
• SpitzerRLKroenkeKWilliamsJBLöweBA brief measure for assessing generalized anxiety disorder: the GAD-7Arch Intern Med2006166101092109716717171
   PubMed Web of Science ®Google Scholar
• AshinaSBuseDCMaizelsMSelf-reported anxiety as a risk factor for migraine chronification. Results from The American Migraine Prevalence and Prevention (AMPP) studyHeadache201050Suppl 1S4 Abstract.
   Google Scholar
• SilbersteinSTfelt-HansenPDodickDWTask Force of the International Headache Society Clinical Trials SubcommitteeGuidelines for controlled trials of prophylactic treatment of chronic migraine in adultsCephalalgia200828548449518294250
   PubMed Web of Science ®Google Scholar
• DienerHCSchornCFBingelUDodickDWThe importance of placebo in headache researchCephalalgia200828101003101118727647
   PubMed Web of Science ®Google Scholar